Methodological quality of systematic reviews on interventions for osteoarthritis: a cross-sectional study

Ref ID 108
First Author I. X. Y. Wu
Journal THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
Year Of Publishing 2020
URL https://journals.sagepub.com/doi/pdf/10.1177/1759720X20959967
Keywords • Rheumatology
• Searching
• Low reporting quality
• Protocols
• Cochrane
• Non-Cochrane reviews
• Risk of bias
Problem(s) • Cochrane reviews more rigorous/higher quality than non-Cochrane reviews
• No registered or published protocol
• Reasons for excluding potentially eligible studies not provided
• Flawed risk of bias undertaken
• Low methodological (AMSTAR) quality
• Insufficient literature searches
Article Type Empirical
Article Subtype Cross-sectional survey/Methodological systematic review
First Author Country Hong Kong
Checklists • AMSTAR 2
Aim To assess the methodological quality (AMSTAR 2) and predictors among systematic reviews of osteoarthritis interventions indexed in three databases from 1 January 2008 to 10 October 2019.
Level of Investigation Descriptive
Summary of Findings Only seven (4.2%) of the included 167 systematic reviews of interventions for osteoarthritis had high methodological quality according to AMSTAR 2. Respectively, eight (4.8%), 25 (15.0%), and 127 (76.0%) systematic reviews had moderate, low, and critically low quality. The main methodological weaknesses were: only 16.8% registered protocol a priori, 4.2% searched literature comprehensively, 25.7% included lists of excluded studies with justifications, and 30.5% assessed risk of bias appropriately by considering allocation concealment, blinding of patients and assessors, random sequence generation and selective reported outcomes. Cochrane reviews [adjusted odds ratio (AOR) 251.5, 95% confidence interval (CI) 35.5–1782.6], being updates of previous SRs (AOR 3.9, 95% CI 1.1–13.7), and SRs published after 2017 (AOR 7.7, 95% CI 2.8–21.5) were positively related to higher methodological quality.
Number of systematic reviews included 167
Number of eligible systematic reviews assessed 1752
Treatment impacted No
Treatment impacted description
Interpretation impacted Not Applicable
Interpretation impacted description